Hongrong Lin

Mrs. Hongrong Lin

Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Renal Failure
Verified
Journal Article
Open access
MLMin Li
Min Li
ZYZhihui Yue
Zhihui Yue
HLHongrong Lin
Hongrong Lin
HWHaiyan Wang
Haiyan Wang
HCHuamu Chen
Huamu Chen
LSLiangzhong Sun
Liangzhong Sun
Coenzyme Q10 (CoQ10) is involved in the biosynthesis of adenosine triphosphate (ATP), and is most abundant in the mitochondrial membrane. The primary CoQ10 deficiency caused by COQ2 defect is mostl...

1 July 2020 in Clinica Chimica Acta
Verified
Journal Article
Closed access
ZYZhihui Yue
Zhihui Yue
HLHongrong Lin
Hongrong Lin
MLMin Li
Min Li
HWHaiyan Wang
Haiyan Wang
TLTing Liu
Ting Liu
LSLiangzhong Sun
Liangzhong Sun

1 May 2017 in Clinical Nephrology
Verified
Journal Article
Closed access
ZYZhihui Yue
Zhihui Yue
HWHaiyan Wang
Haiyan Wang
HLHongrong Lin
Hongrong Lin
JYJuan Yang
Juan Yang
TLTing Liu
Ting Liu
SUSun
Sun
This study explored Wilms' tumor 1 (WT1) mutations in children with, or suspected of having, steroid-resistant nephrotic syndrome (SRNS), referred to or treated in our hospital in the past 6 years as well as the correlation between genotype and phenotype in WT1 mutation-associated nephropathy in Chinese patients. In total, 76 patients participated in the study. WT1 mutations were identified in 15 patients, 5 of whom harbored splice-site mutations in intron 9. Four of these 5 patients exhibited early onset of nephropathy and rapid deterioration of renal function. Missense mutations were detected in 8 patients, 4 of whom harbored hot-site mutations and had early-onset proteinuria. Of these 4 patients, rapid progression to end-stage renal disease was only observed in 1. Nonsense mutations were identified in 2 patients; both had a large number of immature glomeruli in the kidney cortex. Calcineurin inhibitors (CNI) were administered in 8 patients. Two patients with missense mutations and 1 patient with a nonsense mutation achieved complete remission. Two patients with missense mutations and 2 with splice-site mutations showed an improvement. One patient with a splice-site mutation showed no changes. In conclusion, a high WT1 mutation rate was observed in this group of SRNS patients. Patients with splice-site mutations experienced a rapid disease progression, and patients harboring nonsense mutations showed a prominent glomerular developmental delay. CNI therapy was effective in patients with WT1 missense mutations and nonsense mutations. .

1 July 2021 in Clinica Chimica Acta
Verified
Journal Article
Closed access
WFWenjun Fu
Wenjun Fu
MLMin Li
Min Li
HLHongrong Lin
Hongrong Lin
YXYoujing Xu
Youjing Xu
WHWei Han
Wei Han
LSLiangzhong Sun
Liangzhong Sun

1 January 2019
Verified
Journal Article
Closed access
HCHuamu Chen
Huamu Chen
HLHongrong Lin
Hongrong Lin
ZYZhihui Yue
Zhihui Yue
HWHaiyan Wang
Haiyan Wang
JYJunhui Yang
Junhui Yang
LSLiangzhong Sun
Liangzhong Sun